nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—TUBA1A—coronary artery disease	0.502	1	CbGaD
Albendazole—ABCB1—Ticagrelor—coronary artery disease	0.0239	0.0734	CbGbCtD
Albendazole—CYP1A2—Gemfibrozil—coronary artery disease	0.0194	0.0598	CbGbCtD
Albendazole—CYP1A2—Clopidogrel—coronary artery disease	0.0169	0.0518	CbGbCtD
Albendazole—ABCB1—Clopidogrel—coronary artery disease	0.0147	0.0453	CbGbCtD
Albendazole—ABCB1—Perindopril—coronary artery disease	0.0147	0.0453	CbGbCtD
Albendazole—CYP3A4—Ticagrelor—coronary artery disease	0.0143	0.044	CbGbCtD
Albendazole—ABCB1—Pitavastatin—coronary artery disease	0.0129	0.0396	CbGbCtD
Albendazole—ABCB1—Telmisartan—coronary artery disease	0.0129	0.0396	CbGbCtD
Albendazole—CYP3A4—Fenofibrate—coronary artery disease	0.0127	0.0392	CbGbCtD
Albendazole—ABCB1—Enalapril—coronary artery disease	0.0122	0.0376	CbGbCtD
Albendazole—ABCB1—Lisinopril—coronary artery disease	0.0122	0.0376	CbGbCtD
Albendazole—ABCB1—Timolol—coronary artery disease	0.0104	0.0319	CbGbCtD
Albendazole—CYP3A4—Gemfibrozil—coronary artery disease	0.0102	0.0313	CbGbCtD
Albendazole—ABCB1—Ezetimibe—coronary artery disease	0.0095	0.0292	CbGbCtD
Albendazole—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00926	0.0285	CbGbCtD
Albendazole—ABCB1—Captopril—coronary artery disease	0.00914	0.0281	CbGbCtD
Albendazole—CYP3A4—Clopidogrel—coronary artery disease	0.00883	0.0272	CbGbCtD
Albendazole—ABCB1—Simvastatin—coronary artery disease	0.00883	0.0272	CbGbCtD
Albendazole—ABCB1—Lovastatin—coronary artery disease	0.00864	0.0266	CbGbCtD
Albendazole—ABCB1—Pravastatin—coronary artery disease	0.00864	0.0266	CbGbCtD
Albendazole—CYP1A2—Losartan—coronary artery disease	0.00823	0.0253	CbGbCtD
Albendazole—CYP3A4—Eplerenone—coronary artery disease	0.00821	0.0252	CbGbCtD
Albendazole—ABCB1—Atorvastatin—coronary artery disease	0.00787	0.0242	CbGbCtD
Albendazole—CYP3A4—Enalapril—coronary artery disease	0.00732	0.0225	CbGbCtD
Albendazole—ABCB1—Losartan—coronary artery disease	0.0072	0.0221	CbGbCtD
Albendazole—CYP3A4—Rosuvastatin—coronary artery disease	0.00569	0.0175	CbGbCtD
Albendazole—CYP3A4—Ezetimibe—coronary artery disease	0.00569	0.0175	CbGbCtD
Albendazole—CYP3A4—Simvastatin—coronary artery disease	0.00529	0.0163	CbGbCtD
Albendazole—CYP3A4—Pravastatin—coronary artery disease	0.00518	0.0159	CbGbCtD
Albendazole—CYP3A4—Lovastatin—coronary artery disease	0.00518	0.0159	CbGbCtD
Albendazole—CYP3A4—Atorvastatin—coronary artery disease	0.00472	0.0145	CbGbCtD
Albendazole—CYP3A4—Losartan—coronary artery disease	0.00431	0.0133	CbGbCtD
Albendazole—Mebendazole—TUBA1A—coronary artery disease	0.00349	1	CrCbGaD
Albendazole—TUBA1A—cardiac ventricle—coronary artery disease	0.000685	0.114	CbGeAlD
Albendazole—TUBA1A—myocardium—coronary artery disease	0.000644	0.107	CbGeAlD
Albendazole—TUBB4B—cardiac ventricle—coronary artery disease	0.000457	0.0759	CbGeAlD
Albendazole—TUBA1A—heart—coronary artery disease	0.00045	0.0747	CbGeAlD
Albendazole—TUBB4B—myocardium—coronary artery disease	0.000429	0.0714	CbGeAlD
Albendazole—TUBA1A—cardiovascular system—coronary artery disease	0.000424	0.0705	CbGeAlD
Albendazole—TUBA1A—cardiac atrium—coronary artery disease	0.000385	0.0639	CbGeAlD
Albendazole—TUBA1A—blood—coronary artery disease	0.000336	0.0558	CbGeAlD
Albendazole—TUBB4B—heart—coronary artery disease	0.0003	0.0498	CbGeAlD
Albendazole—TUBB4B—cardiovascular system—coronary artery disease	0.000283	0.047	CbGeAlD
Albendazole—TUBB4B—cardiac atrium—coronary artery disease	0.000256	0.0426	CbGeAlD
Albendazole—CYP1A1—cardiac ventricle—coronary artery disease	0.000256	0.0425	CbGeAlD
Albendazole—TUBB4B—blood—coronary artery disease	0.000224	0.0372	CbGeAlD
Albendazole—CYP1A1—heart—coronary artery disease	0.000168	0.0279	CbGeAlD
Albendazole—Abdominal pain—Clopidogrel—coronary artery disease	0.000159	0.0015	CcSEcCtD
Albendazole—Body temperature increased—Clopidogrel—coronary artery disease	0.000159	0.0015	CcSEcCtD
Albendazole—Urticaria—Lovastatin—coronary artery disease	0.000158	0.0015	CcSEcCtD
Albendazole—Abdominal pain—Lovastatin—coronary artery disease	0.000158	0.00149	CcSEcCtD
Albendazole—Body temperature increased—Lovastatin—coronary artery disease	0.000158	0.00149	CcSEcCtD
Albendazole—Thrombocytopenia—Telmisartan—coronary artery disease	0.000157	0.00149	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	0.000157	0.00149	CcSEcCtD
Albendazole—Vertigo—Losartan—coronary artery disease	0.000157	0.00148	CcSEcCtD
Albendazole—Gastrointestinal pain—Eplerenone—coronary artery disease	0.000156	0.00148	CcSEcCtD
Albendazole—Skin disorder—Telmisartan—coronary artery disease	0.000156	0.00148	CcSEcCtD
Albendazole—Leukopenia—Losartan—coronary artery disease	0.000156	0.00148	CcSEcCtD
Albendazole—Hepatitis—Lisinopril—coronary artery disease	0.000156	0.00147	CcSEcCtD
Albendazole—Dizziness—Rosuvastatin—coronary artery disease	0.000155	0.00147	CcSEcCtD
Albendazole—Urticaria—Ezetimibe—coronary artery disease	0.000155	0.00147	CcSEcCtD
Albendazole—Immune system disorder—Ramipril—coronary artery disease	0.000155	0.00147	CcSEcCtD
Albendazole—Nausea—Ticagrelor—coronary artery disease	0.000155	0.00147	CcSEcCtD
Albendazole—Abdominal pain—Ezetimibe—coronary artery disease	0.000155	0.00146	CcSEcCtD
Albendazole—Body temperature increased—Ezetimibe—coronary artery disease	0.000155	0.00146	CcSEcCtD
Albendazole—Urinary tract disorder—Lisinopril—coronary artery disease	0.000154	0.00145	CcSEcCtD
Albendazole—Thrombocytopenia—Captopril—coronary artery disease	0.000153	0.00145	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	0.000153	0.00144	CcSEcCtD
Albendazole—Urethral disorder—Lisinopril—coronary artery disease	0.000153	0.00144	CcSEcCtD
Albendazole—Gastrointestinal pain—Simvastatin—coronary artery disease	0.000152	0.00144	CcSEcCtD
Albendazole—Alopecia—Ramipril—coronary artery disease	0.000152	0.00143	CcSEcCtD
Albendazole—Immune system disorder—Timolol—coronary artery disease	0.000152	0.00143	CcSEcCtD
Albendazole—Abdominal pain—Eplerenone—coronary artery disease	0.000151	0.00143	CcSEcCtD
Albendazole—Body temperature increased—Eplerenone—coronary artery disease	0.000151	0.00143	CcSEcCtD
Albendazole—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000151	0.00143	CcSEcCtD
Albendazole—Hypersensitivity—Fenofibrate—coronary artery disease	0.00015	0.00142	CcSEcCtD
Albendazole—Thrombocytopenia—Perindopril—coronary artery disease	0.000149	0.0014	CcSEcCtD
Albendazole—Alopecia—Timolol—coronary artery disease	0.000148	0.0014	CcSEcCtD
Albendazole—Rash—Rosuvastatin—coronary artery disease	0.000148	0.0014	CcSEcCtD
Albendazole—Dermatitis—Rosuvastatin—coronary artery disease	0.000148	0.0014	CcSEcCtD
Albendazole—Urticaria—Simvastatin—coronary artery disease	0.000148	0.0014	CcSEcCtD
Albendazole—Hypersensitivity—Clopidogrel—coronary artery disease	0.000148	0.0014	CcSEcCtD
Albendazole—Skin disorder—Perindopril—coronary artery disease	0.000147	0.00139	CcSEcCtD
Albendazole—Abdominal pain—Simvastatin—coronary artery disease	0.000147	0.00139	CcSEcCtD
Albendazole—Body temperature increased—Simvastatin—coronary artery disease	0.000147	0.00139	CcSEcCtD
Albendazole—Erythema multiforme—Lisinopril—coronary artery disease	0.000147	0.00139	CcSEcCtD
Albendazole—Headache—Rosuvastatin—coronary artery disease	0.000147	0.00139	CcSEcCtD
Albendazole—Hypersensitivity—Lovastatin—coronary artery disease	0.000147	0.00139	CcSEcCtD
Albendazole—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000145	0.00137	CcSEcCtD
Albendazole—Thrombocytopenia—Furosemide—coronary artery disease	0.000144	0.00137	CcSEcCtD
Albendazole—Rash—Acetylsalicylic acid—coronary artery disease	0.000144	0.00136	CcSEcCtD
Albendazole—Hypersensitivity—Ezetimibe—coronary artery disease	0.000144	0.00136	CcSEcCtD
Albendazole—Gastrointestinal pain—Valsartan—coronary artery disease	0.000144	0.00136	CcSEcCtD
Albendazole—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000144	0.00136	CcSEcCtD
Albendazole—CYP1A1—cardiac atrium—coronary artery disease	0.000144	0.0239	CbGeAlD
Albendazole—Skin disorder—Furosemide—coronary artery disease	0.000143	0.00135	CcSEcCtD
Albendazole—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000143	0.00135	CcSEcCtD
Albendazole—Gastrointestinal pain—Niacin—coronary artery disease	0.00014	0.00132	CcSEcCtD
Albendazole—Urticaria—Valsartan—coronary artery disease	0.00014	0.00132	CcSEcCtD
Albendazole—Nausea—Rosuvastatin—coronary artery disease	0.00014	0.00132	CcSEcCtD
Albendazole—Thrombocytopenia—Losartan—coronary artery disease	0.000139	0.00132	CcSEcCtD
Albendazole—Urticaria—Olmesartan—coronary artery disease	0.000139	0.00132	CcSEcCtD
Albendazole—Abdominal pain—Valsartan—coronary artery disease	0.000139	0.00131	CcSEcCtD
Albendazole—Body temperature increased—Olmesartan—coronary artery disease	0.000138	0.00131	CcSEcCtD
Albendazole—Abdominal pain—Olmesartan—coronary artery disease	0.000138	0.00131	CcSEcCtD
Albendazole—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000138	0.0013	CcSEcCtD
Albendazole—Alopecia—Lisinopril—coronary artery disease	0.000138	0.0013	CcSEcCtD
Albendazole—Hypersensitivity—Simvastatin—coronary artery disease	0.000137	0.0013	CcSEcCtD
Albendazole—Urticaria—Niacin—coronary artery disease	0.000136	0.00128	CcSEcCtD
Albendazole—Nausea—Acetylsalicylic acid—coronary artery disease	0.000136	0.00128	CcSEcCtD
Albendazole—Abdominal pain—Niacin—coronary artery disease	0.000135	0.00128	CcSEcCtD
Albendazole—Body temperature increased—Niacin—coronary artery disease	0.000135	0.00128	CcSEcCtD
Albendazole—Dizziness—Fenofibrate—coronary artery disease	0.000135	0.00128	CcSEcCtD
Albendazole—Vertigo—Ramipril—coronary artery disease	0.000134	0.00127	CcSEcCtD
Albendazole—Leukopenia—Ramipril—coronary artery disease	0.000134	0.00127	CcSEcCtD
Albendazole—Urticaria—Pravastatin—coronary artery disease	0.000134	0.00127	CcSEcCtD
Albendazole—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000134	0.00126	CcSEcCtD
Albendazole—Gastrointestinal pain—Enalapril—coronary artery disease	0.000133	0.00126	CcSEcCtD
Albendazole—Abdominal pain—Pravastatin—coronary artery disease	0.000133	0.00126	CcSEcCtD
Albendazole—Body temperature increased—Pravastatin—coronary artery disease	0.000133	0.00126	CcSEcCtD
Albendazole—Dizziness—Clopidogrel—coronary artery disease	0.000133	0.00125	CcSEcCtD
Albendazole—Dizziness—Lovastatin—coronary artery disease	0.000132	0.00125	CcSEcCtD
Albendazole—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000131	0.00124	CcSEcCtD
Albendazole—Vertigo—Timolol—coronary artery disease	0.000131	0.00124	CcSEcCtD
Albendazole—Urticaria—Trandolapril—coronary artery disease	0.00013	0.00123	CcSEcCtD
Albendazole—Vomiting—Fenofibrate—coronary artery disease	0.00013	0.00123	CcSEcCtD
Albendazole—Hypersensitivity—Valsartan—coronary artery disease	0.00013	0.00123	CcSEcCtD
Albendazole—Urticaria—Enalapril—coronary artery disease	0.000129	0.00122	CcSEcCtD
Albendazole—Abdominal pain—Trandolapril—coronary artery disease	0.000129	0.00122	CcSEcCtD
Albendazole—Body temperature increased—Trandolapril—coronary artery disease	0.000129	0.00122	CcSEcCtD
Albendazole—Dizziness—Ezetimibe—coronary artery disease	0.000129	0.00122	CcSEcCtD
Albendazole—Body temperature increased—Enalapril—coronary artery disease	0.000129	0.00122	CcSEcCtD
Albendazole—Abdominal pain—Enalapril—coronary artery disease	0.000129	0.00122	CcSEcCtD
Albendazole—Rash—Fenofibrate—coronary artery disease	0.000129	0.00122	CcSEcCtD
Albendazole—Dermatitis—Fenofibrate—coronary artery disease	0.000129	0.00121	CcSEcCtD
Albendazole—Headache—Fenofibrate—coronary artery disease	0.000128	0.00121	CcSEcCtD
Albendazole—Gastrointestinal pain—Captopril—coronary artery disease	0.000128	0.00121	CcSEcCtD
Albendazole—Urticaria—Telmisartan—coronary artery disease	0.000128	0.00121	CcSEcCtD
Albendazole—Vomiting—Clopidogrel—coronary artery disease	0.000128	0.00121	CcSEcCtD
Albendazole—Abdominal pain—Telmisartan—coronary artery disease	0.000127	0.0012	CcSEcCtD
Albendazole—Body temperature increased—Telmisartan—coronary artery disease	0.000127	0.0012	CcSEcCtD
Albendazole—CYP1A2—blood—coronary artery disease	0.000127	0.0211	CbGeAlD
Albendazole—Vomiting—Lovastatin—coronary artery disease	0.000127	0.0012	CcSEcCtD
Albendazole—Dizziness—Eplerenone—coronary artery disease	0.000127	0.0012	CcSEcCtD
Albendazole—Rash—Clopidogrel—coronary artery disease	0.000126	0.0012	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000126	0.0012	CcSEcCtD
Albendazole—Dermatitis—Clopidogrel—coronary artery disease	0.000126	0.00119	CcSEcCtD
Albendazole—Hypersensitivity—Niacin—coronary artery disease	0.000126	0.00119	CcSEcCtD
Albendazole—Headache—Clopidogrel—coronary artery disease	0.000126	0.00119	CcSEcCtD
Albendazole—Rash—Lovastatin—coronary artery disease	0.000126	0.00119	CcSEcCtD
Albendazole—Dermatitis—Lovastatin—coronary artery disease	0.000126	0.00119	CcSEcCtD
Albendazole—CYP1A1—blood—coronary artery disease	0.000125	0.0208	CbGeAlD
Albendazole—Headache—Lovastatin—coronary artery disease	0.000125	0.00118	CcSEcCtD
Albendazole—Vomiting—Ezetimibe—coronary artery disease	0.000124	0.00117	CcSEcCtD
Albendazole—Hypersensitivity—Pravastatin—coronary artery disease	0.000124	0.00117	CcSEcCtD
Albendazole—Gastrointestinal pain—Perindopril—coronary artery disease	0.000124	0.00117	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000124	0.00117	CcSEcCtD
Albendazole—Body temperature increased—Captopril—coronary artery disease	0.000124	0.00117	CcSEcCtD
Albendazole—Abdominal pain—Captopril—coronary artery disease	0.000124	0.00117	CcSEcCtD
Albendazole—Dizziness—Simvastatin—coronary artery disease	0.000123	0.00116	CcSEcCtD
Albendazole—Rash—Ezetimibe—coronary artery disease	0.000123	0.00116	CcSEcCtD
Albendazole—Dermatitis—Ezetimibe—coronary artery disease	0.000123	0.00116	CcSEcCtD
Albendazole—Headache—Ezetimibe—coronary artery disease	0.000122	0.00116	CcSEcCtD
Albendazole—Vertigo—Lisinopril—coronary artery disease	0.000122	0.00115	CcSEcCtD
Albendazole—Vomiting—Eplerenone—coronary artery disease	0.000122	0.00115	CcSEcCtD
Albendazole—Leukopenia—Lisinopril—coronary artery disease	0.000121	0.00115	CcSEcCtD
Albendazole—Nausea—Fenofibrate—coronary artery disease	0.000121	0.00115	CcSEcCtD
Albendazole—Gastrointestinal pain—Furosemide—coronary artery disease	0.000121	0.00114	CcSEcCtD
Albendazole—Rash—Eplerenone—coronary artery disease	0.000121	0.00114	CcSEcCtD
Albendazole—Urticaria—Perindopril—coronary artery disease	0.000121	0.00114	CcSEcCtD
Albendazole—Hypersensitivity—Trandolapril—coronary artery disease	0.000121	0.00114	CcSEcCtD
Albendazole—Dermatitis—Eplerenone—coronary artery disease	0.000121	0.00114	CcSEcCtD
Albendazole—Hypersensitivity—Enalapril—coronary artery disease	0.00012	0.00113	CcSEcCtD
Albendazole—Body temperature increased—Perindopril—coronary artery disease	0.00012	0.00113	CcSEcCtD
Albendazole—Abdominal pain—Perindopril—coronary artery disease	0.00012	0.00113	CcSEcCtD
Albendazole—Headache—Eplerenone—coronary artery disease	0.00012	0.00113	CcSEcCtD
Albendazole—Thrombocytopenia—Ramipril—coronary artery disease	0.00012	0.00113	CcSEcCtD
Albendazole—Nausea—Clopidogrel—coronary artery disease	0.000119	0.00113	CcSEcCtD
Albendazole—Skin disorder—Ramipril—coronary artery disease	0.000119	0.00112	CcSEcCtD
Albendazole—Vomiting—Simvastatin—coronary artery disease	0.000119	0.00112	CcSEcCtD
Albendazole—Hypersensitivity—Telmisartan—coronary artery disease	0.000118	0.00112	CcSEcCtD
Albendazole—Nausea—Lovastatin—coronary artery disease	0.000118	0.00112	CcSEcCtD
Albendazole—Rash—Simvastatin—coronary artery disease	0.000118	0.00111	CcSEcCtD
Albendazole—Dermatitis—Simvastatin—coronary artery disease	0.000117	0.00111	CcSEcCtD
Albendazole—Urticaria—Furosemide—coronary artery disease	0.000117	0.00111	CcSEcCtD
Albendazole—Headache—Simvastatin—coronary artery disease	0.000117	0.0011	CcSEcCtD
Albendazole—Body temperature increased—Furosemide—coronary artery disease	0.000117	0.0011	CcSEcCtD
Albendazole—Abdominal pain—Furosemide—coronary artery disease	0.000117	0.0011	CcSEcCtD
Albendazole—Gastrointestinal pain—Losartan—coronary artery disease	0.000116	0.0011	CcSEcCtD
Albendazole—Dizziness—Valsartan—coronary artery disease	0.000116	0.0011	CcSEcCtD
Albendazole—Nausea—Ezetimibe—coronary artery disease	0.000116	0.0011	CcSEcCtD
Albendazole—Skin disorder—Timolol—coronary artery disease	0.000116	0.0011	CcSEcCtD
Albendazole—Dizziness—Olmesartan—coronary artery disease	0.000116	0.00109	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000115	0.00108	CcSEcCtD
Albendazole—Nausea—Eplerenone—coronary artery disease	0.000114	0.00107	CcSEcCtD
Albendazole—Dizziness—Niacin—coronary artery disease	0.000113	0.00107	CcSEcCtD
Albendazole—Urticaria—Losartan—coronary artery disease	0.000113	0.00107	CcSEcCtD
Albendazole—Body temperature increased—Losartan—coronary artery disease	0.000113	0.00106	CcSEcCtD
Albendazole—Abdominal pain—Losartan—coronary artery disease	0.000113	0.00106	CcSEcCtD
Albendazole—Vomiting—Valsartan—coronary artery disease	0.000112	0.00106	CcSEcCtD
Albendazole—Dizziness—Pravastatin—coronary artery disease	0.000111	0.00105	CcSEcCtD
Albendazole—Vomiting—Olmesartan—coronary artery disease	0.000111	0.00105	CcSEcCtD
Albendazole—Rash—Valsartan—coronary artery disease	0.000111	0.00105	CcSEcCtD
Albendazole—Dermatitis—Valsartan—coronary artery disease	0.000111	0.00105	CcSEcCtD
Albendazole—Nausea—Simvastatin—coronary artery disease	0.000111	0.00105	CcSEcCtD
Albendazole—Rash—Olmesartan—coronary artery disease	0.00011	0.00104	CcSEcCtD
Albendazole—Dermatitis—Olmesartan—coronary artery disease	0.00011	0.00104	CcSEcCtD
Albendazole—Headache—Valsartan—coronary artery disease	0.00011	0.00104	CcSEcCtD
Albendazole—Headache—Olmesartan—coronary artery disease	0.00011	0.00104	CcSEcCtD
Albendazole—Vomiting—Niacin—coronary artery disease	0.000109	0.00103	CcSEcCtD
Albendazole—Hypersensitivity—Furosemide—coronary artery disease	0.000109	0.00103	CcSEcCtD
Albendazole—Thrombocytopenia—Lisinopril—coronary artery disease	0.000108	0.00102	CcSEcCtD
Albendazole—Dizziness—Trandolapril—coronary artery disease	0.000108	0.00102	CcSEcCtD
Albendazole—Rash—Niacin—coronary artery disease	0.000108	0.00102	CcSEcCtD
Albendazole—Dermatitis—Niacin—coronary artery disease	0.000108	0.00102	CcSEcCtD
Albendazole—Dizziness—Enalapril—coronary artery disease	0.000108	0.00102	CcSEcCtD
Albendazole—Skin disorder—Lisinopril—coronary artery disease	0.000108	0.00102	CcSEcCtD
Albendazole—Headache—Niacin—coronary artery disease	0.000107	0.00101	CcSEcCtD
Albendazole—Vomiting—Pravastatin—coronary artery disease	0.000107	0.00101	CcSEcCtD
Albendazole—Dizziness—Telmisartan—coronary artery disease	0.000106	0.001	CcSEcCtD
Albendazole—Rash—Pravastatin—coronary artery disease	0.000106	0.001	CcSEcCtD
Albendazole—Dermatitis—Pravastatin—coronary artery disease	0.000106	0.001	CcSEcCtD
Albendazole—Headache—Pravastatin—coronary artery disease	0.000106	0.000998	CcSEcCtD
Albendazole—Hypersensitivity—Losartan—coronary artery disease	0.000105	0.000991	CcSEcCtD
Albendazole—Nausea—Valsartan—coronary artery disease	0.000105	0.000988	CcSEcCtD
Albendazole—Nausea—Olmesartan—coronary artery disease	0.000104	0.000983	CcSEcCtD
Albendazole—Vomiting—Trandolapril—coronary artery disease	0.000104	0.000983	CcSEcCtD
Albendazole—Vomiting—Enalapril—coronary artery disease	0.000104	0.000979	CcSEcCtD
Albendazole—Dizziness—Captopril—coronary artery disease	0.000103	0.000977	CcSEcCtD
Albendazole—Rash—Trandolapril—coronary artery disease	0.000103	0.000975	CcSEcCtD
Albendazole—Dermatitis—Trandolapril—coronary artery disease	0.000103	0.000974	CcSEcCtD
Albendazole—Rash—Enalapril—coronary artery disease	0.000103	0.000971	CcSEcCtD
Albendazole—Dermatitis—Enalapril—coronary artery disease	0.000103	0.00097	CcSEcCtD
Albendazole—Headache—Trandolapril—coronary artery disease	0.000103	0.000969	CcSEcCtD
Albendazole—Vomiting—Telmisartan—coronary artery disease	0.000102	0.000966	CcSEcCtD
Albendazole—Headache—Enalapril—coronary artery disease	0.000102	0.000965	CcSEcCtD
Albendazole—Nausea—Niacin—coronary artery disease	0.000102	0.000961	CcSEcCtD
Albendazole—Rash—Telmisartan—coronary artery disease	0.000101	0.000958	CcSEcCtD
Albendazole—Dermatitis—Telmisartan—coronary artery disease	0.000101	0.000957	CcSEcCtD
Albendazole—Headache—Telmisartan—coronary artery disease	0.000101	0.000952	CcSEcCtD
Albendazole—Dizziness—Perindopril—coronary artery disease	0.0001	0.000948	CcSEcCtD
Albendazole—Nausea—Pravastatin—coronary artery disease	0.0001	0.000946	CcSEcCtD
Albendazole—Gastrointestinal pain—Ramipril—coronary artery disease	9.98e-05	0.000943	CcSEcCtD
Albendazole—Vomiting—Captopril—coronary artery disease	9.94e-05	0.000939	CcSEcCtD
Albendazole—Rash—Captopril—coronary artery disease	9.86e-05	0.000931	CcSEcCtD
Albendazole—Dermatitis—Captopril—coronary artery disease	9.85e-05	0.000931	CcSEcCtD
Albendazole—Headache—Captopril—coronary artery disease	9.79e-05	0.000925	CcSEcCtD
Albendazole—Gastrointestinal pain—Timolol—coronary artery disease	9.76e-05	0.000922	CcSEcCtD
Albendazole—Dizziness—Furosemide—coronary artery disease	9.76e-05	0.000922	CcSEcCtD
Albendazole—Nausea—Trandolapril—coronary artery disease	9.72e-05	0.000919	CcSEcCtD
Albendazole—Urticaria—Ramipril—coronary artery disease	9.7e-05	0.000916	CcSEcCtD
Albendazole—Nausea—Enalapril—coronary artery disease	9.68e-05	0.000915	CcSEcCtD
Albendazole—Vomiting—Perindopril—coronary artery disease	9.65e-05	0.000912	CcSEcCtD
Albendazole—Body temperature increased—Ramipril—coronary artery disease	9.65e-05	0.000912	CcSEcCtD
Albendazole—Abdominal pain—Ramipril—coronary artery disease	9.65e-05	0.000912	CcSEcCtD
Albendazole—Rash—Perindopril—coronary artery disease	9.57e-05	0.000904	CcSEcCtD
Albendazole—Dermatitis—Perindopril—coronary artery disease	9.56e-05	0.000904	CcSEcCtD
Albendazole—Nausea—Telmisartan—coronary artery disease	9.55e-05	0.000902	CcSEcCtD
Albendazole—Headache—Perindopril—coronary artery disease	9.51e-05	0.000899	CcSEcCtD
Albendazole—Urticaria—Timolol—coronary artery disease	9.48e-05	0.000896	CcSEcCtD
Albendazole—Abdominal pain—Timolol—coronary artery disease	9.43e-05	0.000892	CcSEcCtD
Albendazole—Body temperature increased—Timolol—coronary artery disease	9.43e-05	0.000892	CcSEcCtD
Albendazole—Dizziness—Losartan—coronary artery disease	9.41e-05	0.00089	CcSEcCtD
Albendazole—Vomiting—Furosemide—coronary artery disease	9.38e-05	0.000887	CcSEcCtD
Albendazole—Rash—Furosemide—coronary artery disease	9.3e-05	0.000879	CcSEcCtD
Albendazole—Dermatitis—Furosemide—coronary artery disease	9.29e-05	0.000878	CcSEcCtD
Albendazole—Nausea—Captopril—coronary artery disease	9.29e-05	0.000877	CcSEcCtD
Albendazole—Headache—Furosemide—coronary artery disease	9.24e-05	0.000874	CcSEcCtD
Albendazole—CYP3A4—blood—coronary artery disease	9.19e-05	0.0153	CbGeAlD
Albendazole—Gastrointestinal pain—Lisinopril—coronary artery disease	9.05e-05	0.000855	CcSEcCtD
Albendazole—Vomiting—Losartan—coronary artery disease	9.05e-05	0.000855	CcSEcCtD
Albendazole—Nausea—Perindopril—coronary artery disease	9.02e-05	0.000852	CcSEcCtD
Albendazole—Hypersensitivity—Ramipril—coronary artery disease	8.99e-05	0.00085	CcSEcCtD
Albendazole—Rash—Losartan—coronary artery disease	8.98e-05	0.000848	CcSEcCtD
Albendazole—Dermatitis—Losartan—coronary artery disease	8.97e-05	0.000847	CcSEcCtD
Albendazole—Headache—Losartan—coronary artery disease	8.92e-05	0.000843	CcSEcCtD
Albendazole—Urticaria—Lisinopril—coronary artery disease	8.79e-05	0.000831	CcSEcCtD
Albendazole—Hypersensitivity—Timolol—coronary artery disease	8.79e-05	0.000831	CcSEcCtD
Albendazole—Nausea—Furosemide—coronary artery disease	8.76e-05	0.000828	CcSEcCtD
Albendazole—Abdominal pain—Lisinopril—coronary artery disease	8.75e-05	0.000827	CcSEcCtD
Albendazole—Body temperature increased—Lisinopril—coronary artery disease	8.75e-05	0.000827	CcSEcCtD
Albendazole—ABCB1—heart—coronary artery disease	8.72e-05	0.0145	CbGeAlD
Albendazole—Nausea—Losartan—coronary artery disease	8.46e-05	0.000799	CcSEcCtD
Albendazole—ABCB1—cardiovascular system—coronary artery disease	8.23e-05	0.0137	CbGeAlD
Albendazole—Hypersensitivity—Lisinopril—coronary artery disease	8.16e-05	0.000771	CcSEcCtD
Albendazole—Dizziness—Ramipril—coronary artery disease	8.07e-05	0.000763	CcSEcCtD
Albendazole—Dizziness—Timolol—coronary artery disease	7.89e-05	0.000746	CcSEcCtD
Albendazole—Vomiting—Ramipril—coronary artery disease	7.76e-05	0.000733	CcSEcCtD
Albendazole—Rash—Ramipril—coronary artery disease	7.7e-05	0.000727	CcSEcCtD
Albendazole—Dermatitis—Ramipril—coronary artery disease	7.69e-05	0.000727	CcSEcCtD
Albendazole—Headache—Ramipril—coronary artery disease	7.65e-05	0.000723	CcSEcCtD
Albendazole—Vomiting—Timolol—coronary artery disease	7.59e-05	0.000717	CcSEcCtD
Albendazole—Rash—Timolol—coronary artery disease	7.52e-05	0.000711	CcSEcCtD
Albendazole—Dermatitis—Timolol—coronary artery disease	7.52e-05	0.00071	CcSEcCtD
Albendazole—Headache—Timolol—coronary artery disease	7.48e-05	0.000706	CcSEcCtD
Albendazole—Dizziness—Lisinopril—coronary artery disease	7.32e-05	0.000692	CcSEcCtD
Albendazole—Nausea—Ramipril—coronary artery disease	7.25e-05	0.000685	CcSEcCtD
Albendazole—Nausea—Timolol—coronary artery disease	7.09e-05	0.00067	CcSEcCtD
Albendazole—Vomiting—Lisinopril—coronary artery disease	7.04e-05	0.000665	CcSEcCtD
Albendazole—Rash—Lisinopril—coronary artery disease	6.98e-05	0.00066	CcSEcCtD
Albendazole—Dermatitis—Lisinopril—coronary artery disease	6.97e-05	0.000659	CcSEcCtD
Albendazole—Headache—Lisinopril—coronary artery disease	6.94e-05	0.000655	CcSEcCtD
Albendazole—Nausea—Lisinopril—coronary artery disease	6.58e-05	0.000621	CcSEcCtD
Albendazole—ABCB1—blood—coronary artery disease	6.51e-05	0.0108	CbGeAlD
Albendazole—CYP1A1—Metabolism—SLC9A1—coronary artery disease	5.76e-06	0.0001	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTT1—coronary artery disease	5.76e-06	0.0001	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLCB3—coronary artery disease	5.75e-06	0.0001	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GCLC—coronary artery disease	5.7e-06	9.91e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CETP—coronary artery disease	5.7e-06	9.91e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOA5—coronary artery disease	5.69e-06	9.9e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PYGB—coronary artery disease	5.68e-06	9.88e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CKB—coronary artery disease	5.68e-06	9.88e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	5.67e-06	9.86e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SDC1—coronary artery disease	5.63e-06	9.8e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—P4HB—coronary artery disease	5.58e-06	9.71e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PDHA1—coronary artery disease	5.57e-06	9.7e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GCLM—coronary artery disease	5.57e-06	9.7e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLA2G1B—coronary artery disease	5.48e-06	9.53e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	5.47e-06	9.51e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	5.4e-06	9.4e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP11B2—coronary artery disease	5.4e-06	9.39e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TXNRD1—coronary artery disease	5.4e-06	9.39e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM2—coronary artery disease	5.34e-06	9.28e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—DLAT—coronary artery disease	5.34e-06	9.28e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—COX5B—coronary artery disease	5.34e-06	9.28e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLIN1—coronary artery disease	5.34e-06	9.28e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PFKFB3—coronary artery disease	5.34e-06	9.28e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSMA6—coronary artery disease	5.32e-06	9.26e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSMB5—coronary artery disease	5.32e-06	9.26e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC22A3—coronary artery disease	5.32e-06	9.25e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.31e-06	9.24e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ARNTL—coronary artery disease	5.24e-06	9.12e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HADH—coronary artery disease	5.24e-06	9.12e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CTGF—coronary artery disease	5.2e-06	9.04e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—VCAN—coronary artery disease	5.16e-06	8.99e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	5.16e-06	8.98e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMGCR—coronary artery disease	5.15e-06	8.96e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GOT2—coronary artery disease	5.15e-06	8.96e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDOA—coronary artery disease	5.12e-06	8.92e-05	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	5.09e-06	8.86e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.06e-06	8.8e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	5.03e-06	8.76e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—DCN—coronary artery disease	4.97e-06	8.66e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA2—coronary artery disease	4.97e-06	8.64e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	4.97e-06	8.64e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX2—coronary artery disease	4.97e-06	8.64e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SULT1A1—coronary artery disease	4.91e-06	8.54e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCG5—coronary artery disease	4.91e-06	8.54e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX4—coronary artery disease	4.91e-06	8.54e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HK1—coronary artery disease	4.91e-06	8.54e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	4.9e-06	8.53e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HADHA—coronary artery disease	4.85e-06	8.44e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDH2—coronary artery disease	4.84e-06	8.42e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKR1B1—coronary artery disease	4.83e-06	8.4e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HK2—coronary artery disease	4.83e-06	8.4e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA1—coronary artery disease	4.79e-06	8.34e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LPA—coronary artery disease	4.74e-06	8.25e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PLCB1—coronary artery disease	4.74e-06	8.24e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LIPC—coronary artery disease	4.72e-06	8.21e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HBA1—coronary artery disease	4.72e-06	8.21e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2C19—coronary artery disease	4.72e-06	8.21e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3C2A—coronary artery disease	4.72e-06	8.21e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOC3—coronary artery disease	4.69e-06	8.15e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LDLR—coronary artery disease	4.66e-06	8.1e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.65e-06	8.08e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.63e-06	8.05e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC9A1—coronary artery disease	4.6e-06	8.01e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—coronary artery disease	4.6e-06	8.01e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCA1—coronary artery disease	4.59e-06	7.99e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLCB3—coronary artery disease	4.59e-06	7.99e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GCLC—coronary artery disease	4.55e-06	7.92e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CETP—coronary artery disease	4.55e-06	7.92e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA5—coronary artery disease	4.54e-06	7.91e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LCAT—coronary artery disease	4.54e-06	7.89e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.54e-06	7.89e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SDC1—coronary artery disease	4.5e-06	7.83e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	4.47e-06	7.77e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—P4HB—coronary artery disease	4.46e-06	7.75e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA4—coronary artery disease	4.45e-06	7.75e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GGT1—coronary artery disease	4.45e-06	7.74e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GOT1—coronary artery disease	4.45e-06	7.74e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.41e-06	7.68e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	4.37e-06	7.61e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.32e-06	7.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.3e-06	7.48e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCLM—coronary artery disease	4.3e-06	7.48e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.27e-06	7.44e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSMA6—coronary artery disease	4.25e-06	7.39e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSMB5—coronary artery disease	4.25e-06	7.39e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.17e-06	7.25e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.17e-06	7.25e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CTGF—coronary artery disease	4.15e-06	7.22e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—VCAN—coronary artery disease	4.12e-06	7.17e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMGCR—coronary artery disease	4.11e-06	7.16e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GOT2—coronary artery disease	4.11e-06	7.16e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.1e-06	7.14e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDOA—coronary artery disease	4.09e-06	7.12e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HADH—coronary artery disease	4.04e-06	7.04e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.04e-06	7.04e-05	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	4.03e-06	7.02e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTP1—coronary artery disease	3.99e-06	6.95e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—DCN—coronary artery disease	3.97e-06	6.91e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	3.96e-06	6.89e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMOX1—coronary artery disease	3.94e-06	6.85e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAT—coronary artery disease	3.89e-06	6.76e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDH2—coronary artery disease	3.86e-06	6.72e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA2—coronary artery disease	3.83e-06	6.67e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.83e-06	6.67e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX2—coronary artery disease	3.83e-06	6.67e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX4—coronary artery disease	3.79e-06	6.59e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.79e-06	6.59e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HK1—coronary artery disease	3.79e-06	6.59e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.79e-06	6.59e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLCB1—coronary artery disease	3.78e-06	6.58e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOB—coronary artery disease	3.77e-06	6.57e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.77e-06	6.55e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HBA1—coronary artery disease	3.76e-06	6.55e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LIPC—coronary artery disease	3.76e-06	6.55e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2C19—coronary artery disease	3.76e-06	6.55e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	3.76e-06	6.55e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HADHA—coronary artery disease	3.74e-06	6.51e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOC3—coronary artery disease	3.74e-06	6.51e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LDLR—coronary artery disease	3.72e-06	6.47e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.71e-06	6.46e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.7e-06	6.44e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTT1—coronary artery disease	3.67e-06	6.39e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC9A1—coronary artery disease	3.67e-06	6.39e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—coronary artery disease	3.67e-06	6.39e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCA1—coronary artery disease	3.67e-06	6.38e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LPA—coronary artery disease	3.66e-06	6.36e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GCLC—coronary artery disease	3.63e-06	6.32e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CETP—coronary artery disease	3.63e-06	6.32e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LPL—coronary artery disease	3.6e-06	6.27e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SDC1—coronary artery disease	3.59e-06	6.25e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GGT1—coronary artery disease	3.55e-06	6.18e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GOT1—coronary artery disease	3.55e-06	6.18e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.54e-06	6.16e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPX1—coronary artery disease	3.51e-06	6.12e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA5—coronary artery disease	3.51e-06	6.1e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—P4HB—coronary artery disease	3.44e-06	5.98e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CD36—coronary artery disease	3.42e-06	5.96e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.39e-06	5.9e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.39e-06	5.9e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.39e-06	5.89e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPP2CA—coronary artery disease	3.38e-06	5.88e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.37e-06	5.87e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CTGF—coronary artery disease	3.31e-06	5.77e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.28e-06	5.72e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GOT2—coronary artery disease	3.28e-06	5.72e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—coronary artery disease	3.24e-06	5.64e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTP1—coronary artery disease	3.19e-06	5.55e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—VCAN—coronary artery disease	3.18e-06	5.54e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARGC1A—coronary artery disease	3.16e-06	5.5e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.16e-06	5.49e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMOX1—coronary artery disease	3.15e-06	5.47e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAT—coronary artery disease	3.1e-06	5.4e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AGT—coronary artery disease	3.08e-06	5.36e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—DCN—coronary artery disease	3.06e-06	5.33e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.02e-06	5.26e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOE—coronary artery disease	3.02e-06	5.25e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOB—coronary artery disease	3.01e-06	5.24e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOA1—coronary artery disease	2.99e-06	5.19e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.98e-06	5.19e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.96e-06	5.16e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—coronary artery disease	2.93e-06	5.1e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.93e-06	5.09e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.91e-06	5.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.91e-06	5.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HBA1—coronary artery disease	2.91e-06	5.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LIPC—coronary artery disease	2.91e-06	5.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOC3—coronary artery disease	2.89e-06	5.02e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LPL—coronary artery disease	2.88e-06	5.01e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LDLR—coronary artery disease	2.87e-06	4.99e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.86e-06	4.97e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.84e-06	4.93e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.84e-06	4.93e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GOT1—coronary artery disease	2.84e-06	4.93e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GGT1—coronary artery disease	2.84e-06	4.93e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPX1—coronary artery disease	2.81e-06	4.89e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CETP—coronary artery disease	2.8e-06	4.88e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCLC—coronary artery disease	2.8e-06	4.88e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SDC1—coronary artery disease	2.77e-06	4.82e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CD36—coronary artery disease	2.73e-06	4.76e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.7e-06	4.7e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—coronary artery disease	2.63e-06	4.58e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.62e-06	4.56e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.62e-06	4.56e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—POMC—coronary artery disease	2.59e-06	4.51e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—coronary artery disease	2.59e-06	4.51e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CTGF—coronary artery disease	2.56e-06	4.45e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.55e-06	4.43e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GOT2—coronary artery disease	2.53e-06	4.41e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.53e-06	4.41e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.52e-06	4.39e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.51e-06	4.37e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAT—coronary artery disease	2.48e-06	4.31e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AGT—coronary artery disease	2.46e-06	4.28e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOE—coronary artery disease	2.41e-06	4.2e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOB—coronary artery disease	2.41e-06	4.19e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOA1—coronary artery disease	2.38e-06	4.15e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—coronary artery disease	2.37e-06	4.12e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.34e-06	4.07e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.33e-06	4.06e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LPL—coronary artery disease	2.3e-06	4e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NOS3—coronary artery disease	2.26e-06	3.94e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.26e-06	3.93e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX1—coronary artery disease	2.24e-06	3.9e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GGT1—coronary artery disease	2.19e-06	3.81e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GOT1—coronary artery disease	2.19e-06	3.81e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CD36—coronary artery disease	2.18e-06	3.8e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.16e-06	3.75e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—coronary artery disease	2.1e-06	3.66e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—POMC—coronary artery disease	2.07e-06	3.61e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—coronary artery disease	2.07e-06	3.6e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.07e-06	3.6e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.97e-06	3.42e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AGT—coronary artery disease	1.97e-06	3.42e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.95e-06	3.39e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.94e-06	3.37e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOE—coronary artery disease	1.93e-06	3.35e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAT—coronary artery disease	1.91e-06	3.33e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA1—coronary artery disease	1.9e-06	3.31e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—coronary artery disease	1.89e-06	3.29e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOB—coronary artery disease	1.86e-06	3.23e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.82e-06	3.17e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NOS3—coronary artery disease	1.81e-06	3.14e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.81e-06	3.14e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LPL—coronary artery disease	1.77e-06	3.08e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX1—coronary artery disease	1.73e-06	3.01e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CD36—coronary artery disease	1.68e-06	2.93e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—coronary artery disease	1.68e-06	2.92e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.66e-06	2.89e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—POMC—coronary artery disease	1.65e-06	2.88e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—coronary artery disease	1.65e-06	2.88e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.6e-06	2.78e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AGT—coronary artery disease	1.52e-06	2.64e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—coronary artery disease	1.51e-06	2.62e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOE—coronary artery disease	1.49e-06	2.59e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA1—coronary artery disease	1.47e-06	2.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NOS3—coronary artery disease	1.44e-06	2.51e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.32e-06	2.3e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—coronary artery disease	1.29e-06	2.25e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—POMC—coronary artery disease	1.28e-06	2.22e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—coronary artery disease	1.27e-06	2.22e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—coronary artery disease	1.16e-06	2.03e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NOS3—coronary artery disease	1.11e-06	1.94e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—coronary artery disease	1.04e-06	1.81e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.02e-06	1.77e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.02e-06	1.77e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—coronary artery disease	8.31e-07	1.45e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—coronary artery disease	8.12e-07	1.41e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—coronary artery disease	6.63e-07	1.15e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.26e-07	1.09e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—coronary artery disease	5.12e-07	8.91e-06	CbGpPWpGaD
